publish

medicines
Cela vous concerne plus que vous ne le pensez : les risques et le potentiel des accords internationaux d’investissement pour les discussions sur l’Accord sur les aspects des droits de propriété intellectuelle qui touchent au commerce et la Covid-19 à l’OMC
IISD | 23-Dec-2021
Les discussions sur une décision sur les ADPIC en lien avec la Covid-19 et visant à accélérer la production et la distribution équitable de vaccins et de médicaments se poursuivent mais les accords d’investissement en sont absents.
keywords: covid, health, intellectual property, investment | BITs, investor-state disputes | ISDS, medicines
They concern you more than you know: On the perils and potential of international investment agreements for the Agreement on Trade-Related Aspects of Intellectual Property Rights and COVID-19 discussions at the World Trade Organization
IISD | 23-Dec-2021
Talks on a possible COVID-19-related TRIPS decision aimed at scaling up vaccine and therapeutics production and equitable distribution continue but investment agreements are absent from them.
keywords: covid, health, intellectual property, investment | BITs, investor-state disputes | ISDS, medicines
Can pharmaceutical companies counter the waiver of their patents for Covid-19 vaccines through investment treaty arbitration?
Kluwer Arbitration Blog | 27-May-2021
The patent waiver initiative may give rise to claims under the expropriation standard, and to a lesser degree, under the FET standard.
keywords: covid, investor-state disputes | ISDS, medicines
Las farmacéuticas blindan los contratos de la vacuna Covid19 con arbitraje
CIAR Global | 8-Oct-2020
El proyecto de ley para avanzar en la compra de la vacuna Covid19 en Argentina contemplará la petición de los laboratorios farmacéuticos de incluir la protección jurídica a través de arbitraje, condición que tienen que respetar todos los países.
keywords: covid, health, investor-state disputes | ISDS, medicines
La pandemia: un gran negocio para empresas transnacionales
Biodiversidad en América Latina | 11-Aug-2020
La Internacional de Servicios Públicos, en asociación con la Fundación Friedrich Ebert, está produciendo una serie de cuatro artículos investigando como los tratados de libre comercio, el neoliberalismo y la falta de justicia fiscal socavaron la respuesta sanitaria y socioeconómica de la crisis generada por la pandemia de Covid-19.
keywords: corporate interests , covid, health, intellectual property, investor-state disputes | ISDS, medicines
Covid-19: Why India doesn’t need to worry about investor-State dispute settlement claims
Hindustan Times | 2-Apr-2020
In order to halt the spread of the coronavirus pandemic (Covid-19) and to boost the public health care system and preparedness, India has taken several regulatory steps.
keywords: covid, health, India, investor-state disputes | ISDS, medicines
Farmacéutica española SM Pharma inicia arbitraje contra Venezuela
CIAR Global | 30-Jan-2020
El empresario español Raimundo Santamarta, uno de los propietarios de la farmacéutica SM Pharma, ha presentado una notificación de arbitraje contra la República Bolivariana de Venezuela bajo el Acuerdo para la Protección de Inversiones entre el Reino de España y Venezuela.
keywords: investor-state disputes | ISDS, medicines, Venezuela
Novartis vs. Colombia: How Big Pharma sabotaged the struggle for affordable cancer treatment
Red Carpet Courts | 1-Jan-2020
keywords: Colombia, health, intellectual property, investor-state disputes | ISDS, medicines, Switzerland
Eli Lilly vs. Canada: Medicine patents
ISDS Corporate Attacks | 1-Jan-2020
keywords: Canada, health, intellectual property, investor-state disputes | ISDS, medicines, NAFTA | USMCA, US
Cour permanente d’arbitrage de La Haye : Un autre cas de gagné pour l’État mauricien
Zinfos Moris | 16-Sep-2019
Deux investisseurs français, le professeur Christian Doutremepuich et Francois Doutremepuich, avait initié une action pour obtenir un arbitrage.
keywords: France, investor-state disputes | ISDS, Mauritius, medicines

0 | 10 | 20 | 30 | 40 | 50